Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10213494 Treatment of synucleinopathies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 24, 2016
Date of Patent
February 26, 2019
Patent Application Number
15079709
Patent Citations Received
‌
US Patent 11060113 Gene therapies for lysosomal disorders
‌
US Patent 11273149 Compositions and methods for the treatment of amyotrophic lateral sclerosis, Parkinson's disease, Parkinson's disease with dementia, dementia with Lewy bodies, and multiple system atrophy
0
‌
US Patent 11661585 Gene therapies for lysosomal disorders
0
‌
US Patent 11802294 Gene therapies for lysosomal disorders
‌
US Patent 11903985 Gene therapies for lysosomal disorders
0
‌
US Patent 11993790 Gene therapies for lysosomal disorders
0
‌
US Patent 12016843 Compositions and methods for the treatment of amyotrophic lateral sclerosis, parkinson's disease, parkinson's disease with dementia, dementia with lewy bodies, and multiple system atrophy
0
‌
US Patent 10837028 Gene therapies for lysosomal disorders
Patent Inventor Names
Seng H. Cheng
0
Michael Schlossmacher
0
Valerie Cullen
0
Lamya Shihabuddin
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10213494
Patent Primary Examiner
‌
Scott Long

Find more entities like US Patent 10213494 Treatment of synucleinopathies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo